Latest filings (excl ownership)
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
10 Apr 24
8-K
Changes in Registrant's Certifying Accountant
9 Apr 24
8-K
Completed First Surgeries With Next-Generation Lap-Band® 2.0 FLEX
4 Apr 24
10-K
2023 FY
Annual report
1 Apr 24
8-K
Submission of Matters to a Vote of Security Holders
26 Feb 24
DEF 14A
Definitive proxy
24 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
18 Jan 24
PRE 14A
Preliminary proxy
5 Jan 24
8-K
Entry into a Material Definitive Agreement
29 Nov 23
10-Q
2023 Q3
Quarterly report
8 Nov 23
8-K
Third Quarter Core Operating Expenses Reduced 37% Compared to Third Quarter of 2022
8 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
13 Oct 23
8-K
ReShape Lifesciences® Announces Pricing of $3.0 Million Public Offering
5 Oct 23
424B4
Prospectus supplement with pricing info
3 Oct 23
EFFECT
Notice of effectiveness
2 Oct 23
CORRESP
Correspondence with SEC
28 Sep 23
S-1/A
IPO registration (amended)
27 Sep 23
8-K
ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon System
22 Sep 23
S-1/A
IPO registration (amended)
11 Sep 23
UPLOAD
Letter from SEC
30 Aug 23
S-1
IPO registration
25 Aug 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
8-K
Results of Operations and Financial Condition
7 Aug 23
S-8
Registration of securities for employees
23 Jun 23
8-K
Executing a Plan For Growth and Profitability With a Balance Sheet Bolstered By Approximately $12.7 Million Raised in 2023
15 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
8-K
ReShape Lifesciences Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market
26 Apr 23
424B5
Prospectus supplement for primary offering
24 Apr 23
10-K
2022 FY
Annual report
17 Apr 23
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
13 Apr 23
NT 10-K
Notice of late annual filing
3 Apr 23
8-K
Entry into a Material Definitive Agreement
21 Mar 23
8-K
ReShape Lifesciences Announces Pricing of Upsized
10 Feb 23
424B4
Prospectus supplement with pricing info
8 Feb 23
EFFECT
Notice of effectiveness
6 Feb 23
S-1MEF
Registration of additional securities for an S-1
3 Feb 23
S-1/A
IPO registration (amended)
3 Feb 23
CORRESP
Correspondence with SEC
3 Feb 23
CORRESP
Correspondence with SEC
3 Feb 23
RW WD
Withdrawal of registration withdrawal request
2 Feb 23
Latest ownership filings
SC 13G
Schneid Yair
17 Jan 24
3
Yair Schneid
16 Jan 24
4
THOMAS STANKOVICH
8 Nov 23
4
THOMAS STANKOVICH
19 Jul 23
4
THOMAS STANKOVICH
6 Jul 23
SC 13D
Matthew Joseph Nachtrab Revocable Trust 2014
17 Mar 23
4
THOMAS STANKOVICH
7 Mar 23
SC 13D
FOLEY & LARDNER/ FA
15 Feb 23
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 23
4
THOMAS STANKOVICH
20 Dec 22
4
THOMAS STANKOVICH
10 Nov 22
4
THOMAS STANKOVICH
6 Oct 22
4
THOMAS STANKOVICH
12 Sep 22
3
Paul F. Hickey
26 Aug 22
4
THOMAS STANKOVICH
11 Aug 22
4
Barton P. Bandy
11 Aug 22
4
THOMAS STANKOVICH
6 Jul 22
4
Barton P. Bandy
6 Jul 22
4
Barton P. Bandy
6 Jun 22
4
THOMAS STANKOVICH
6 Jun 22
4
THOMAS STANKOVICH
1 Jun 22
4
Barton P. Bandy
12 May 22
4
THOMAS STANKOVICH
12 May 22
4
THOMAS STANKOVICH
8 Apr 22
4
Barton P. Bandy
8 Apr 22
4
THOMAS STANKOVICH
2 Mar 22
4
Barton P. Bandy
2 Mar 22
SC 13G/A
ARMISTICE CAPITAL, LLC
15 Feb 22
SC 13G/A
INTERWEST PARTNERS X LP
14 Feb 22
4
Barton P. Bandy
2 Feb 22
4
THOMAS STANKOVICH
2 Feb 22
4
Barton P. Bandy
28 Jan 22
4
THOMAS STANKOVICH
28 Jan 22
4
Barton P. Bandy
9 Dec 21
4
THOMAS STANKOVICH
9 Dec 21
4
THOMAS STANKOVICH
18 Nov 21
4
Barton P. Bandy
16 Nov 21
4
THOMAS STANKOVICH
16 Nov 21
4
THOMAS STANKOVICH
12 Oct 21
4
Barton P. Bandy
12 Oct 21